A COVID Vaccine for All – Scientific American

Credit: Tetra Images

Some good news for global vaccine equity.

This article in Scientific American talks about a COVID vaccine made using proven methods and licensed to the world with no patents. It can be manufactured in existing facilities in lower income countries and distributed by established supply lines. No squabbling about patent fees or vaccine donations or pharma profits. This could get more people vaccinated in less time than the promises of vaccine donations by richer countries, with more self-reliance and dignity.

This vaccine was developed by the Texas Children’s Hospital Center for Vaccine Development and Baylor College of Medicine

With proved technology and no-frills tech transfer, CORBEVAX is poised to reach hundreds of millions in the coming weeks

licensed, with no patents or strings attached

safe, effective and can be locally produced at very high quantities

easy to store and inexpensive

Good news is nice. Go read the article in Scientific American.

rjb

About arjaybe

Jim has fought forest fires and controlled traffic in the air and on the sea. Now he writes stories.
This entry was posted in Uncategorized. Bookmark the permalink.

2 Responses to A COVID Vaccine for All – Scientific American

  1. verendun says:

    Thank you for that information. Good news indeed especially given how the “advanced” countries have been behaving and not giving vaccinations to other countries as they promised they would.

Please let us know what you think. No registration required.

This site uses Akismet to reduce spam. Learn how your comment data is processed.